Education
About Us
Working with TipRanks
Follow Us
Clearpoint Neuro, Inc. (CLPT)
:CLPT
CLPT Stock Chart & Stats
$27.32
-$0.35(-2.27%)
At close: 4:00 PM EST
$27.32
-$0.35(-2.27%)
Day’s Range― - ―
52-Week Range$9.76 - $30.10
Previous CloseN/A
Volume88.39K
Average Volume (3M)1.20M
Market Cap
$482.70M
Enterprise ValueN/A
Total Cash (Recent Filing)$41.54M
Total Debt (Recent Filing)$6.61M
Price to Earnings (P/E)―
Beta1.42
Next Earnings
Mar 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding28,427,418
10 Day Avg. Volume1,099,604
30 Day Avg. Volume1,196,875
Financial Highlights & Ratios
PEG Ratio0.99
Price to Book (P/B)16.37
Price to Sales (P/S)13.24
P/FCF Ratio-45.06
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$30.00Price Target Upside9.81% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance SheetThe balance sheet is solid with over $20M of cash and no debt.
EarningsFunctional Neuro growth was strong at 43% year-over-year.
Partnership DevelopmentsThe partner business recently had significant developments that accelerate $100s of millions of revenue opportunities, with 70%+ gross margins.
Bears Say
Market Entry TimingRevenue opportunities from the partner business are expected to be on the market as early as late 2026.
ClearPoint Neuro News
CLPT FAQ
What was Clearpoint Neuro, Inc.’s price range in the past 12 months?
Clearpoint Neuro, Inc. lowest stock price was $9.76 and its highest was $30.10 in the past 12 months.
What is Clearpoint Neuro, Inc.’s market cap?
Clearpoint Neuro, Inc.’s market cap is $482.70M.
When is Clearpoint Neuro, Inc.’s upcoming earnings report date?
Clearpoint Neuro, Inc.’s upcoming earnings report date is Mar 04, 2026 which is in 116 days.
How were Clearpoint Neuro, Inc.’s earnings last quarter?
Clearpoint Neuro, Inc. released its earnings results on Nov 06, 2025. The company reported -$0.21 earnings per share for the quarter, missing the consensus estimate of -$0.2 by -$0.01.
Is Clearpoint Neuro, Inc. overvalued?
According to Wall Street analysts Clearpoint Neuro, Inc.’s price is currently Undervalued.
Does Clearpoint Neuro, Inc. pay dividends?
Clearpoint Neuro, Inc. does not currently pay dividends.
What is Clearpoint Neuro, Inc.’s EPS estimate?
Clearpoint Neuro, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clearpoint Neuro, Inc. have?
Clearpoint Neuro, Inc. has 28,427,418 shares outstanding.
What happened to Clearpoint Neuro, Inc.’s price movement after its last earnings report?
Clearpoint Neuro, Inc. reported an EPS of -$0.21 in its last earnings report, missing expectations of -$0.2. Following the earnings report the stock price went up 7.362%.
Which hedge fund is a major shareholder of Clearpoint Neuro, Inc.?
Currently, no hedge funds are holding shares in CLPT
ClearPoint Neuro Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$30.00 (9.81% Upside)
$30.00 (9.81% Upside)
Blogger Sentiment
Bullish
CLPT Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 14.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 11.6%
Last 30 Days ▲ 12.2%
Last 30 Days ▲ 12.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
36.24%
12-Months-Change
Fundamentals
Return on Equity
-85.68%
Trailing 12-Months
Asset Growth
19.58%
Trailing 12-Months
Company Description
Clearpoint Neuro, Inc.
ClearPoint Neuro, Inc. is a medical technology company focused on developing and commercializing innovative solutions for the treatment of neurological disorders. The company operates primarily in the healthcare sector, specializing in neurosurgical devices and related services. ClearPoint's core product is its ClearPoint Neuro Navigation System, which enables precise targeting of brain structures for therapeutic procedures, including drug delivery and biopsy. Additionally, the company is involved in advancing its technology through strategic collaborations and clinical trials aimed at improving patient outcomes in neurosurgery.
CLPT Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth, successful product launches, and strategic expansions. Despite some challenges with gross margin and operating expenses, the company's strong cash position and strategic partnerships position it well for future growth.View all CLPT earnings summariesCLPT Stock 12 Month Forecast
Average Price Target
$30.00
▲(9.81% Upside)
Technical Analysis
Ownership Overview
10.59% Insiders
8.11% Mutual Funds
7.18% Other Institutional Investors
66.03% Public Companies and Individual Investors